Daniel Bradbury - Net Worth and Insider Trading

Daniel Bradbury Net Worth

The estimated net worth of Daniel Bradbury is at least $12 Million dollars as of 2023-06-09. Daniel Bradbury is the Director of Corcept Therapeutics Inc and owns about 177,925 shares of Corcept Therapeutics Inc (CORT) stock worth over $4 Million. Daniel Bradbury is the Director of Castle Biosciences Inc and owns about 295,954 shares of Castle Biosciences Inc (CSTL) stock worth over $4 Million. Daniel Bradbury is also the Director of Illumina Inc and owns about 15,324 shares of Illumina Inc (ILMN) stock worth over $3 Million. Besides these, Daniel Bradbury also holds Intercept Pharmaceuticals Inc (ICPT) . Details can be seen in Daniel Bradbury's Latest Holdings Summary section.

Transaction Summary of Daniel Bradbury

To

Daniel Bradbury Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Bradbury owns 10 companies in total, including Castle Biosciences Inc (CSTL) , Panacea Acquisition Corp (PANA.U) , and Intercept Pharmaceuticals Inc (ICPT) among others .

Click here to see the complete history of Daniel Bradbury’s form 4 insider trades.

Insider Ownership Summary of Daniel Bradbury

Ticker Comapny Transaction Date Type of Owner
CSTL Castle Biosciences Inc 2019-07-24 director
PANA.U Panacea Acquisition Corp 2020-06-30 director
ICPT Intercept Pharmaceuticals Inc 2020-05-28 director
EQ Equillium Inc 2018-10-11 director & Chief Executive Officer
GERN Geron Corp 2012-09-26 director
CORT Corcept Therapeutics Inc 2016-07-21 director
ILMN Illumina Inc 2004-01-07 director
BMR BioMed Realty Trust Inc 2016-01-27 director
PRTK Paratek Pharmaceuticals Inc 2006-05-09 director
NUVB Nuvation Bio Inc 2020-06-30 director

Daniel Bradbury Latest Holdings Summary

Daniel Bradbury currently owns a total of 4 stocks. Among these stocks, Daniel Bradbury owns 177,925 shares of Corcept Therapeutics Inc (CORT) as of December 10, 2015, with a value of $4 Million and a weighting of 36.35%. Daniel Bradbury owns 295,954 shares of Castle Biosciences Inc (CSTL) as of May 5, 2023, with a value of $4 Million and a weighting of 36.04%. Daniel Bradbury also owns 15,324 shares of Illumina Inc (ILMN) as of May 25, 2017, with a value of $3 Million and a weighting of 26.4%. The other 1 stocks Intercept Pharmaceuticals Inc (ICPT) have a combined weighting of 1.21% among all his current holdings.

Latest Holdings of Daniel Bradbury

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2015-12-10 177,925 24.04 4,277,317
CSTL Castle Biosciences Inc 2023-05-05 295,954 14.33 4,241,021
ILMN Illumina Inc 2017-05-25 15,324 202.72 3,106,481
ICPT Intercept Pharmaceuticals Inc 2018-04-09 11,642 12.25 142,615

Holding Weightings of Daniel Bradbury


Daniel Bradbury Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Bradbury has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 20,000 shares on December 10, 2015, which brought Daniel Bradbury around $97,000.

According to the SEC Form 4 filings, Daniel Bradbury has made a total of 52 transactions in Castle Biosciences Inc (CSTL) over the past 5 years, including 0 buys and 52 sells. The most-recent trade in Castle Biosciences Inc is the sale of 25,000 shares on May 5, 2023, which brought Daniel Bradbury around $540,750.

According to the SEC Form 4 filings, Daniel Bradbury has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 600 shares on May 25, 2017, which brought Daniel Bradbury around $104,166.

More details on Daniel Bradbury's insider transactions can be found in the Insider Trading History of Daniel Bradbury table.

Insider Trading History of Daniel Bradbury

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
CSTL
Castle Biosciences Inc
2023-05-05
Sell
25,000.00
-7.79%
$21.63
$540,750.00
295,954.00
$14.33
-33.75%
2023-05-08
CSTL
Castle Biosciences Inc
2023-04-05
Sell
7,100.00
-2.16%
$22.20
$157,620.00
320,954.00
$14.33
-35.45%
2023-04-06
CSTL
Castle Biosciences Inc
2023-04-04
Sell
17,900.00
-5.17%
$22.16
$396,664.00
328,054.00
$14.33
-35.33%
2023-04-05
CSTL
Castle Biosciences Inc
2023-03-03
Sell
25,000.00
-6.74%
$23.97
$599,250.00
345,954.00
$14.33
-40.22%
2023-03-06
CSTL
Castle Biosciences Inc
2023-02-02
Sell
25,000.00
-6.31%
$27.48
$687,000.00
370,954.00
$14.33
-47.85%
2023-02-03
CSTL
Castle Biosciences Inc
2023-01-03
Sell
7,704.00
-1.91%
$22.89
$176,345.00
395,954.00
$14.33
-37.40%
2023-01-05
CSTL
Castle Biosciences Inc
2022-12-01
Sell
7,704.00
-1.87%
$23.95
$184,511.00
403,658.00
$14.33
-40.17%
2022-12-05
CSTL
Castle Biosciences Inc
2022-11-01
Sell
7,704.00
-1.84%
$25.49
$196,375.00
411,362.00
$14.33
-43.78%
2022-11-03
CSTL
Castle Biosciences Inc
2022-10-03
Sell
7,704.00
-1.81%
$27.17
$209,318.00
419,066.00
$14.33
-47.26%
2022-10-05
CSTL
Castle Biosciences Inc
2022-09-01
Sell
7,704.00
-1.77%
$28.08
$216,328.00
426,770.00
$14.33
-48.97%
2022-09-06
CSTL
Castle Biosciences Inc
2022-08-01
Sell
7,704.00
-1.74%
$27.47
$211,629.00
434,474.00
$14.33
-47.83%
2022-08-03
CSTL
Castle Biosciences Inc
2022-03-30
Sell
17,704.00
-4.45%
$45.12
$798,804.00
380,351.00
$14.33
-68.24%
2022-03-31
CSTL
Castle Biosciences Inc
2022-02-23
Sell
17,704.00
-4.08%
$39.13
$692,758.00
415,759.00
$14.33
-63.38%
2022-02-24
CSTL
Castle Biosciences Inc
2022-02-10
Sell
17,704.00
-3.92%
$46.00
$814,384.00
433,463.00
$14.33
-68.85%
2022-02-11
CSTL
Castle Biosciences Inc
2022-01-24
Sell
14,631.00
-3.14%
$35.42
$518,230.00
451,167.00
$14.33
-59.54%
2022-01-26
CSTL
Castle Biosciences Inc
2022-01-20
Sell
15,604.00
-3.24%
$35.26
$550,197.00
465,798.00
$14.33
-59.36%
2022-01-24
CSTL
Castle Biosciences Inc
2022-01-18
Sell
2,470.00
-0.51%
$35.30
$87,191.00
481,402.00
$14.33
-59.41%
2022-01-20
CSTL
Castle Biosciences Inc
2022-01-05
Sell
32,706.00
-6.33%
$42.86
$1,401,780.00
483,872.00
$14.33
-66.57%
2022-01-06
CSTL
Castle Biosciences Inc
2022-01-04
Sell
16,053.00
-3.11%
$43.55
$699,108.00
500,525.00
$14.33
-67.10%
2022-06-13
CSTL
Castle Biosciences Inc
2021-11-08
Sell
5,554.00
-1.06%
$61.21
$339,960.00
516,578.00
$14.33
-76.59%
-
Total 119
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Bradbury Trading Performance

GuruFocus tracks the stock performance after each of Daniel Bradbury's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Bradbury is 34.02%. GuruFocus also compares Daniel Bradbury's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Bradbury within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel Bradbury's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel Bradbury

Average Relative Return

108.69%

Average relative return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 17.82 34.02 49.72 108.69 35.7 32.96
Relative Return to S&P 500(%) 15.65 28.67 38.11 92.39 26.13 20.14

Daniel Bradbury Ownership Network

Ownership Network List of Daniel Bradbury

No Data

Ownership Network Relation of Daniel Bradbury


Daniel Bradbury Owned Company Details

What does Castle Biosciences Inc do?

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Who are the key executives at Castle Biosciences Inc?

Daniel Bradbury is the director of Castle Biosciences Inc. Other key executives at Castle Biosciences Inc include Chief Commercial Officer Tobin W Juvenal , Chief Operating Officer Kristen M Oelschlager , and 10 percent owner Mgc Venture Partners 2013, L.p. .

Castle Biosciences Inc (CSTL) Insider Trades Summary

Over the past 18 months, Daniel Bradbury made 19 insider transaction in Castle Biosciences Inc (CSTL) with a net sale of 280,800. Other recent insider transactions involving Castle Biosciences Inc (CSTL) include a net sale of 197,244 shares made by Derek J Maetzold , a net purchase of 2,482 shares made by Tiffany Olson , and a net purchase of 4,800 shares made by Ellen Goldberg .

In summary, during the past 3 months, insiders sold 91,860 shares of Castle Biosciences Inc (CSTL) in total and bought 4,800 shares, with a net sale of 87,060 shares. During the past 18 months, 478,044 shares of Castle Biosciences Inc (CSTL) were sold and 7,282 shares were bought by its insiders, resulting in a net sale of 470,762 shares.

Castle Biosciences Inc (CSTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Castle Biosciences Inc Insider Transactions

No Available Data

Daniel Bradbury Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Bradbury. You might contact Daniel Bradbury via mailing address: Biobrit, Llc, 2223 Avenida De La Playa, Suite 108, La Jolla Ca 92037.